Global Cephalosporin Drugs Market to reach a market size of $14.1 billion by 2025 - KBV Research

Published Date: 31-07-2019

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Cephalosporin Drugs Market, published by KBV research, The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period.

The Third-Generation Cephalosporin Drugs market dominated the Global Cephalosporin Drugs Market by Generation in 2018, growing at a CAGR of 3.6 % during the forecast period. The Second-Generation Cephalosporin Drugs market is expected to witness a CAGR of 3.2% during (2019 - 2025).

The Injections market dominated the Global Cephalosporin Drugs Market by Route of Administration in 2018, growing at a CAGR of 3.3 % during the forecast period. The Oral Drugs market is expected to witness a CAGR of 3.5% during (2019 - 2025).

The Asia Pacific market dominated the Global Skin Infection Market by Region in 2018, growing at a CAGR of 3.1 % during the forecast period. The Europe market is expected to witness a CAGR of 3.3% during (2019 - 2025). Additionally, The North America market is expected to witness a CAGR of 5.1% during (2019 - 2025).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Global Cephalosporin Drugs Market Segmentation

By Generation

  • First-Generation Cephalosporin
  • Second-Generation Cephalosporin
  • Third-Generation Cephalosporin
  • Fourth-Generation Cephalosporin
  • Fifth-Generation Cephalosporin

By Application

  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Sexually Transmitted Infection
  • Others

By Route of Administration

  • Injections
  • Oral Drugs

By Type

  • Branded
  • Generic

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • ABBOTT Laboratories
  • Teva Pharmaceuticals Industries Ltd.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Baxter International, Inc.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Cephalosporin Drugs Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.